GSK reports Q1 sales decline by Selina McKee | Apr 25, 2018 | News | 0 GlaxoSmithKline has booked a 2 percent dip in revenues for the first quarter to £7.2 billion, after results were hit by a “significant currency impact” and lower sales of prescription drugs. Read More
GSK poaches AZ’ Luke Miels for pharma business by Selina McKee | Jan 20, 2017 | News | 0 GlaxoSmithKline has announced that AstraZeneca’s Luke Miels has been appointed president of its Global Pharmaceuticals division. Read More